Exact Sciences Corp - Company Profile

Powered by

All the data and insights you need on Exact Sciences Corp in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Exact Sciences Corp Strategy Report

  • Understand Exact Sciences Corp position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Exact Sciences Corp: Overview

Select Item

Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the development of tests for various types of cancers. The company’s flagship product, Cologuard test is a US FDA-approved non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of colorectal cancer and pre-cancer. It uses a multi-target approach to detect DNA and hemoglobin biomarkers is related to colorectal cancer. The company also offers Oncotype DX gene expression tests for prostate, breast, and colon cancers; and Oncotype DX AR-V7 Nucleus Detect test, a liquid-based test designed for advanced stage prostate cancer. It operates manufacturing and laboratory facilities in Madison, Wisconsin to process Cologuard tests. Exact Sciences is headquartered in Madison, Wisconsin, the US.

 Gain a 360-degree view of Exact Sciences Corp and make more informed decisions for your business Gain a 360-degree view of Exact Sciences Corp and make more informed decisions for your business Find out more
Headquarters United States of America
Address 5505 Endeavor Lane, Madison, Wisconsin, 53719
Website www.exactsciences.com
Telephone 1 608 2845700
No of Employees 6,300
Industry Medical Equipment
Ticker Symbol & Exchange EXAS (NASD)
Revenue (2022) $2.1B 17.9% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -4.7% (2022 vs 2021)
Market Cap* $11.5B
Net Profit Margin (2022) XYZ 11.3% (2022 vs 2021)
* As of and is in US$
View Exact Sciences Corp financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Exact Sciences Corp premium industry data and analytics

80+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

50+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Exact Sciences Corp (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Exact Sciences Corp’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Cologuard Test - Non-Invasive Stool-Based DNA (sDNA) Screening Test Cologuard
Oncotype DX Gene Expression Tests - for Breast, Prostate and Colon Cancers LBgard
Oncotype DX AR-V7 Nucleus Detect Test - for Advanced Stage Prostate Cancer
XYZ
XYZ
XYZ
Understand Exact Sciences Corp portfolio and identify potential areas for collaboration Understand Exact Sciences Corp portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Litigation In November, the company filed a lawsuit against Geneoscopy, Inc. in the United States District Court for the District of Delaware to stop Geneoscopy from making, using, selling, or offering for sale of Geneoscopy’s ColoSense product.
2023 Contracts/Agreements In September, the company entered into an agreement to acquire Resolution Bioscience from Agilent Technologies, Inc.
2023 Contracts/Agreements In August, the company entered into a multi-year, co-exclusive agreement with Watchmaker Genomics to develop and commercialize the breakthrough DNA methylation analysis technology, TET-assisted pyridine borane sequencing (TAPS).
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Exact Sciences Corp Natera Inc Lineage Cell Therapeutics Inc StageZero Life Sciences Ltd Epigenomics AG
Headquarters United States of America United States of America United States of America Canada Germany
City Madison Austin Carlsbad Richmond Hill Berlin
State/Province Wisconsin Texas California Ontario Baden-Wurttemberg
No. of Employees 6,300 2,958 78 40 18
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Kevin T. Conroy President; Chairman; Chief Executive Officer Executive Board 2014 56
Jeffrey T. Elliott Chief Financial Officer; Chief Operating Officer; Executive Vice President Senior Management 2021 44
Gary Frings Chief Information Officer Senior Management 2015 -
Scott Coward Chief Legal Officer; Secretary; Executive Vice President Senior Management 2018 57
Graham P. Lidgard, Ph.D. Chief Science Officer Senior Management 2009 71
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Exact Sciences Corp key executives to enhance your sales strategy Gain insight into Exact Sciences Corp key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward